Risk of Hemolytic Uremic Syndrome Related to Treatment of <i>Escherichia coli</i> O157 Infection with Different Antimicrobial Classes

Treatment of Shiga toxin-producing <i>Escherichia coli</i> O157 (O157) diarrhea with antimicrobials might alter the risk of hemolytic uremic syndrome (HUS). However, full characterization of which antimicrobials might affect risk is lacking, particularly among adults. To inform clinical management,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Rajal K. Mody, Robert M. Hoekstra, Magdalena Kendall Scott, John Dunn, Kirk Smith, Melissa Tobin-D’Angelo, Beletshachew Shiferaw, Katie Wymore, Paula Clogher, Amanda Palmer, Nicole Comstock, Kari Burzlaff, Sarah Lathrop, Sharon Hurd, Patricia M. Griffin
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-09-01
Saila:	Microorganisms
Gaiak:	hemolytic uremic syndrome <i>Escherichia coli</i> O157 diarrhea
Sarrera elektronikoa:	https://www.mdpi.com/2076-2607/9/9/1997
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!